PFSA Profusa, Inc. Common Stock
Healthcare$0.37-2.29%ClosedMarket Cap: $204,676
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.02
P/S
0.00
EV/EBITDA
-0.36
DCF Value
$-55.30
FCF Yield
-8819.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
154.2%
ROA
-4920.2%
ROIC
193.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-4.0M | $-3.5M | $— | — |
| Q4 null | $0.00 | NaN% | $-3.6M | $-8.6M | $— | — |
| FY null | $0.00 | NaN% | $-13.2M | $-35.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-21.7M | $-22.2M | $— | — |
| Q2 null | $0.00 | NaN% | $-967.1K | $-8.2M | $— | — |
| Q1 null | $0.00 | NaN% | $-1.4M | $-2.7M | $— | — |
| Q4 null | $0.00 | NaN% | $-309.8K | $-7.6M | $— | — |
| FY null | $0.00 | NaN% | $-4.5M | $-9.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-1.1M | $-2.5M | $— | — |
| Q2 null | $0.00 | NaN% | $-253.1K | $-397.5K | $— | — |
| Q1 null | $0.00 | NaN% | $-1.3M | $-2.4M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-460.2K | $236.0K | $2.94 | — |